相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial
Y. Lecrubier et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia
JLR Martin et al.
EUROPEAN PSYCHIATRY (2006)
Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs - A meta-analysis
G Kemmler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Control group bias in randomized atypical antipsychotic medication trials for schizophrenia
SW Woods et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia
RR Conley et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial
N Schooler et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia
D Naber et al.
ACTA PSYCHIATRICA SCANDINAVICA (2005)
Olanzapine treatment of residual positive and negative symptoms
RW Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets
P Chue et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Dose response and dose equivalence of antipsychotics
JM Davis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia
A Mortimer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia:: A placebo-controlled trial
MH Corrigan et al.
BIOLOGICAL PSYCHIATRY (2004)
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and Schizoaffective disorder
HY Meltzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder
GM Simpson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
I Bitter et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse
CM Beasley et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia
S Kasper et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia - A randomized controlled trial
R Rosenheck et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
SW Woods et al.
BIOLOGICAL PSYCHIATRY (2003)
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzapine versus haloperidol
JA Lieberman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder
SG Potkin et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
JM Kane et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand
O Gureje et al.
SCHIZOPHRENIA RESEARCH (2003)
The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia
CW Ritchie et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study
DE Casey et al.
PSYCHOPHARMACOLOGY (2003)
Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial
JS Kennedy et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia
DV Jeste et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Amisulpride vs. risperidone in chronic schizophrenia: Results of a 6-month double-blind study
D Sechter et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
JM Kane et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study
M Arato et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)
Switching to olanzapine from previous antipsychotics: A regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific
CT Lee et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia
SR Hirsch et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
J Volavka et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
JG Csernansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: Short-term results at two months
S Martin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study
XY Zhang et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2001)
A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) study
J Mullen et al.
CLINICAL THERAPEUTICS (2001)
Clozapine and haloperidol in moderately refractory schizophrenia - A 6-month randomized and double-blind comparison
JM Kane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia
JM Azorin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Dropout rates in randomised antipsychotic drug trials
K Wahlbeck et al.
PSYCHOPHARMACOLOGY (2001)
A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder
RR Conley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial
AH Heck et al.
SCHIZOPHRENIA RESEARCH (2000)
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
J Geddes et al.
BRITISH MEDICAL JOURNAL (2000)
Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia:: results of a multicentre, double-blind study (the Amisulpride Study Group)
P Carrière et al.
EUROPEAN PSYCHIATRY (2000)
A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia
SJ Cooper et al.
ACTA PSYCHIATRICA SCANDINAVICA (2000)
A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia
DL Copolov et al.
PSYCHOLOGICAL MEDICINE (2000)
分享论文
